Skip to content

Causes Of End Stage Renal Disease In Patients Undergoing Regular Hemodialysis

CausesOf End Stage Renal Disease In Patients Undergoing Regular Hemodialysis In Assiut University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03779750
Enrollment
200
Registered
2018-12-19
Start date
2019-01-01
Completion date
2021-03-01
Last updated
2018-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease Patients

Brief summary

CKD is defined as kidney damage for ≥3 months, as defined by structural and or functional abnormalities of the kidney, with or without decreased GFR or GFR \<60 mL/min/1.73m2 for ≥3 months, with or without kidney damage. CKD is classified based on cause, GFR category, and albuminuria category (CGA). ESRD has become a public health problem worldwide, with recent reports showing that the total number of ESRD patients has been growing dramatically.

Detailed description

The prevalence ESRD undergoing maintenance dialysis in 2010 was 284 individuals per million population (pmp) worldwide, which has increased 1.7 times from 165 pmp patients in 1990. In Egypt, the prevalence of dialysis patients has increased from 225 pmp in 1996 to 483 pmp in 2008(according to last Egyptian renal registry) and the main causes of ESKD in Egypt, other than diabetic nephropathy, included hypertensive kidney disease, chronic glomerulonephritis, unknown etiology, chronic pyelonephritis, schistosomal obstructive uropathy, and schistosomal nephropathy . It is well established that diabetic kidney disease is the most common cause or in combination with hypertensive nephropathy are the most common causes of end-stage renal disease (ESRD) in developed and developing countries. Patient survival in diabetics on maintenance renal replacement therapy including hemodialysis (HD), peritoneal dialysis (PD) and kidney transplantation is significantly lower than that seen in nondiabetics with ESRD. The poor prognosis of diabetic patients with ESRD is partly due to presence of significant cardiovascular disease, problems with vascular access, more susceptible to infections, foot ulcer, and hemodynamic instability during HD. Hemodialysis (HD) is the first line of renal replacement therapy in the investigator's country. It is well known that patients on RRT are of greater risk for complications and worse prognosis in comparison to patients with the same co-morbidities but not on RRT. The most common complicatons of hemodialysis are hypotensive episodes, muscular cramps, itching, arrhythmias,and anaphylactic responses during the sessions.

Interventions

DIAGNOSTIC_TESTs.creatinine

All ESRD patients on regular hemodialysis in dialysis unit of Assiut university Hospital duing one year. will be subjected to 3- Routine investigations including complete blood picture ,blood urea , s.creatinine,urine analysis , calcium, phosphorus, and parathyroid hormone.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* All ESRD patients \>18years old in Assuit University Hospital dialysis unit . * Patients on regular haemodialysis for more than six months.

Exclusion criteria

* ESRD patients\<18years old . * patients with acute kidney injury . * patients on haemodialysis for less than six months.

Design outcomes

Primary

MeasureTime frameDescription
To find out the possible etiologies of ESRD in patients undergoing regular hemodialysis in Assiut university hospital.Within one year* prevalence of ESRD on regular hemodialysis(in percentage )among different age groups ( measured by years) * frequencies(in percentage)of different etiologies in ESRD on regular hemodialysis.
To do registration for ESRD patients undergoing regular haemodialysis in assuit university hospital dialysis unitWithin one year• Relation between different causes of ESRD and life expectance.

Countries

Egypt

Contacts

Primary ContactHudna A Ahmed, resident
hudna.abdullah@yahoo.com00201096365187
Backup ContactEssam M Abdel Aziz, lecture Dr
essam.nephro@gmail.com00201009699081

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026